3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
11
Prostatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Prostatic Neoplasms, Castration-Resistant
4
Neoplasm Metastasis
4
Stomach Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Breast Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
1
Neoplasms by Site
1
Interventions
fludarabine
11
Cyclophosphamide
10
fludarabine phosphate
8
Whole-Body Irradiation
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
CPX-351
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
ivosidenib
3
X-Rays
3
Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Docetaxel
×
30 days
×
Clear all
No trials found.